Cellectar Biosciences, Inc.

Cellectar Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates

Presented updated data at the International Workshop for Waldenström Macroglobulinemia (IWWM) supporting the planned accelerated approval strategy…